Crossmark

The association of immune-inflammation indices at multiple time points with treatment response and survival in advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1186/s12957-025-03833-y

Published Online: 2025-05-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yaqing

Xu, Jianping

Zhang, Lijuan

Cai, Zhigang
License Information

Text and Data Mining valid from 2025-05-16

Version of Record valid from 2025-05-16
More Information

Article History

Received: 7 March 2025

Accepted: 1 May 2025

First Online: 16 May 2025

Declarations

:

: The study was approved by the Ethics Committee. Informed consent was gained from each patient or their families.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below